US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

45.85

+1.673.79%

Volume:2K

Turnover:95.66K

Market Cap:5.73M

PE:- -

High:45.88

Open:44.96

Low:44.81

Close:44.17

52wk High:45.88

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:1.06

T/O Rate:1.68%

Dividend:0.62

Dividend Rate:1.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Roche receives FDA approval for companion diagnostic tests for Ziihera

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)

Argenx Se : Wells Fargo Raises Target Price to $1415 from $1350

THOMSON REUTERS

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Argenx : UBS Raises to Buy from Neutral

THOMSON REUTERS

Circio and Full Circles join forces on non-viral in vivo cell therapy platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/TBXU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":45.8456,"timestamp":1788379200000,"preClose":44.172,"halted":0,"volume":2099,"delay":0,"changeRate":0.03788825500316944,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Pre-Mkt","change":1.6736,"latestTime":"09-03 04:19:49 EDT","open":44.96,"high":45.88,"low":44.81,"amount":95658.868856,"amplitude":0.024223,"askPrice":72.89,"askSize":100,"bidPrice":18.43,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":45.8456,"sharesOutstanding":100001,"nav":44.235,"aum":5529447.64,"dividendRate":0.013563,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.88,"preClose":45.8456,"latestTime":"18:07 EDT","volume":11,"amount":509.5236,"timestamp":1788386861384,"change":0.0344,"changeRate":0.00075,"amplitude":0},"volumeRatio":1.0594589137896224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0594589137896224,"shares":125000,"dividePrice":0.6218,"high":45.88,"amplitude":0.024223,"preClose":44.172,"low":44.81,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":45.8456,"eps":0,"divideRate":0.013563,"volume":2099,"delay":0,"ttmEps":0,"open":44.96,"prevYearClose":31.065,"prevWeekClose":42.5761,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.3509,"twentyDayClose":35.755,"sixtyDayClose":29.6232},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662708397","title":"JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708397","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708397?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:58","pubTimestamp":1787824692,"startTime":"0","endTime":"0","summary":"JW Cayman Therapeutics FY26 H1 IFRS loss narrows 81.14% to RMB 50.4 million; revenue rises 4.7% to RMB 111.4 millionJW Cayman Therapeutics posted IFRS revenue of RMB 111.4 million, up 4.7% year over y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8Yh1j4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","BK1583","BK1574","LU0823416689.USD","BK1161","LU2237438978.USD","LU2362541273.HKD","LU2468319806.SGD","LU0823434583.USD","BK4585","LU1917777945.USD","LU0289739699.SGD","LU2023250504.SGD","BK4139","LU0058720904.USD","LU2106854487.HKD","LU2362540622.SGD","LU0882574055.USD","BBH","LU0109394709.USD","BK4588","LU0053666078.USD","TBXU","LU1974910355.USD","LU0823434740.USD","02126","LU2362541513.USD","LU0114720955.EUR","REGN","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZN","BBH","LU0029864427.USD","LU1023059063.AUD","PJP","LU1983299246.USD","BK4599","IBB","LU1267930573.SGD","LU2456880835.USD","PBE","LU2237443465.HKD","BK4533","LU0128525929.USD","BK4585","AMGN","LU1829250122.USD","BIB","LU0889565916.HKD","IE00BJT1NW94.SGD","LU2417539215.USD","LU1061106388.HKD","TBXU","IE0002141913.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B3T34201.USD","LU2236285917.USD","LU2237443895.HKD","LU2237443978.SGD","BK4588","BK4568","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2112291526.USD","LU2242646821.SGD","IBBQ","BK4007","LU0122379950.USD","AZNH","LU0289739699.SGD","BK4581","LU0432979614.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","IE0009355771.USD","LU1571399168.USD","LU0868494617.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","IBBQ","IE00BFTCPJ56.SGD","LU2237443549.SGD","LU2237443622.USD","BK4581","AZNH","LU1057294990.SGD","LU2237443465.HKD","PJP","LU2112291526.USD","BK4007","BK4533","LU0109394709.USD","AZN","LU1983299246.USD","LU2456880835.USD","LU0128525929.USD","IBB","BIB","LU0889565916.HKD","LU2242646821.SGD","LU2237443895.HKD","TBXU","AMGN","LU0289739699.SGD","LU0310800379.SGD","LU1061106388.HKD","LU0868494617.USD","LU2242652126.USD","LU0029864427.USD","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0708994859.HKD","LU2089984988.USD","BK4534","LU1829250122.USD","PBE","BBH","BK4566","LU0432979614.USD","LU2237443382.USD","LU1571399168.USD","LU2237443978.SGD","LU2462157665.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1267930573.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775710","title":"Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775710?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813720,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has been selected as a constituent of the JPX-Nikkei Mid and Small Ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","IE00B2B36J28.USD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU2462157665.USD","VERX","BK4567","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IBB","IBBQ","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4533","LU1585245621.USD","PBE","BIB","IE0002141913.USD","IE00B19Z3581.USD","LU2089984988.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU1559883803.SGD","LU1815336091.USD","LU0566484027.USD","JPX","BK4532","BBH","SG9999013999.USD","LU0432979614.USD","TBXU","IE0002270589.USD","LU1093756168.USD","LU1430594728.SGD","BK4023","LU0079474960.USD","SG9999001176.USD","LU2417539215.USD","SGXZ57979304.SGD","LU2456880835.USD","LU0234570918.USD","LU0823416689.USD","LU1778281490.HKD","BK4585","IDNA","LU0109394709.USD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477574","title":"Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813711,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has updated its earlier disclosures on changes to directors and offic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2456880835.USD","LU0061475181.USD","LU2362541273.HKD","SG9999001176.USD","VRTX","BK4585","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2417539215.USD","LU2462157665.USD","PBE","LU0417517546.SGD","LU2362541513.USD","IE00B19Z3581.USD","BK4567","BBH","BK4532","BIB","GNMX","LU0757428866.USD","TBXU","VERX","IE00B2B36J28.USD","LU1815336091.USD","LU0823416689.USD","IBBQ","LU0234570918.USD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","LU0058720904.USD","LU1559883803.SGD","IE00BJT1NW94.SGD","LU2236285917.USD","SGXZ57979304.SGD","BK4023","LU0566484027.USD","LU1035775433.USD","LU0109394709.USD","LU1674673428.USD","BK4533","LU0289739699.SGD","LU0079474960.USD","LU0320765992.SGD","IBB","LU1093756325.SGD","IDNA","LU0256863811.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051770623.HKD","IBB","03165","LU1481600234.SGD","BIB","LU0997586432.USD","LU1153584641.USD","LU1571399168.USD","LU0345777659.USD","LU0997586515.USD","LU1119994496.HKD","LU1880407132.USD","LU1003077747.HKD","IE00BFTCPJ56.SGD","LU0052756011.USD","LU0738911758.USD","LU1267930490.SGD","LU2237443382.USD","AZN.UK","LU0661504455.SGD","LU0823434583.USD","LU1170363599.USD","LU1829250122.USD","LU0432979614.USD","LU2293690082.USD","LU0575583348.USD","LU0047473722.EUR","PBE","LU2242652126.USD","BBH","LU0792757196.USD","BK4588","BK4599","TBXU","LU0887340254.USD","LU1974910355.USD","LU0077335932.USD","LU1057294990.SGD","LU0266013472.USD","LU0122379950.USD","PJP","LU0310799852.SGD","AMGN","SGXZ57979304.SGD","LU0640478417.SGD","LU2237443622.USD","LU3187612489.SGD","REGN","IBBQ","LU0972486137.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","BBH","AMGN","LU2112291526.USD","LU2242646821.SGD","LU1023059063.AUD","SG9999001440.SGD","LU1571399168.USD","LU2089984988.USD","BK4588","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0289739699.SGD","TBXU","LU0109394709.USD","PBE","LU0058720904.USD","LU1061106388.HKD","BK4599","LU0122379950.USD","IE0009355771.USD","LU1057294990.SGD","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4566","IE00BJT1NW94.SGD","PJP","BK4534","IE00B2B36J28.USD","IE0002141913.USD","LU0320765992.SGD","LU0868494617.USD","BK4533","BK4139","IBB","BIB","IBBQ","LU1983299246.USD","LU0889565916.HKD","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","PJP","BBH","LU0868494617.USD","BK4139","LU1983299246.USD","LU2112291526.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4533","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IBB","LU1571399168.USD","LU2242646821.SGD","LU0058720904.USD","SG9999001440.SGD","PBE","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","IBBQ","TBXU","LU0122379950.USD","IE00BJT1NW94.SGD","BIB","IE0002141913.USD","BK4585","AMGN","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4566","LU2468319806.SGD","LU1057294990.SGD","LU0109394709.USD","BK4599","BK4581","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4578","SG9999015978.USD","IBBQ","TMED","IE00B19Z3581.USD","GNOM","BK4533","BK4551","LU0320765992.SGD","LU1674673691.USD","LU2357627491.SGD","LU0058720904.USD","GILD","MEDI","MRNX","IDNA","IE00B7SZLL34.SGD","SG9999015952.SGD","LU1585245621.USD","BK4548","LU0122379950.USD","LU0861579265.USD","LU0965509101.SGD","BK4532","LGHT","IBB","LU0965508806.USD","LU0109394709.USD","LU1934455863.HKD","MRNY","LU1839511570.USD","LU2324357040.USD","LU1057294990.SGD","LU1674673428.USD","LU2087621335.USD","BMED","IE00BZ1G4Q59.USD","BK4585","IE0002270589.USD","LU1571399168.USD","BBH","WDNA","BIB","TBXU","BK4534","LU0965509283.SGD","MRNA","LU0234570918.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662417787","title":"Gilead Sciences Updates Financial Calendar with Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662417787","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662417787?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:05","pubTimestamp":1787774725,"startTime":"0","endTime":"0","summary":"Gilead Sciences updates financial calendar with investor conference presentationsGilead executives will present at the Wells Fargo Annual Healthcare Conference on September 9 at 11:00 a.m. ET.Presenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8cjLQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0109394709.USD","LU1037948897.HKD","IBBQ","LU0861579265.USD","LU0889565916.HKD","LU1674673691.USD","LU1934455277.USD","LU1778281490.HKD","BK4568","LU0234570918.USD","LU1585245621.USD","LU2087621335.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4585","BK4588","LU0823416689.USD","BIB","IE0002270589.USD","TBXU","MEDI","IE00B3T34201.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4583","BK4550","LU0965508806.USD","LU1674673428.USD","LU1057294990.SGD","LU0859254822.USD","LU2089984988.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1023059063.AUD","SG9999015952.SGD","TMED","LU1571399168.USD","LU0965509283.SGD","BBH","IBB","LU1037948541.HKD","GILD","LU0882574055.USD","BMED","LU1066053197.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU1069344957.HKD","LU0289739699.SGD","GNMX","LU0058720904.USD","LU0320765992.SGD","IDNA","TBXU","LU0109394709.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU0079474960.USD","LU0417517546.SGD","LU0432979614.USD","LU2417539215.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BIB","LU2362541513.USD","PBE","IE00B19Z3581.USD","IBB","LU2362541273.HKD","LU1093756168.USD","IE00B2B36J28.USD","SG9999013999.USD","IE00B19Z9P08.USD","LU2089984988.USD","LU0889565916.HKD","LU1674673428.USD","BBH","LU1674673691.USD","SG9999001176.USD","LU0256863811.USD","IBBQ","SGXZ57979304.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU1430594728.SGD","LU2462157665.USD","BK4139","IE0002141913.USD","VRTX","LU0234570918.USD","LU1778281490.HKD","LU1035775433.USD","BK4533","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","MRNX","IEIH","IYH","FRTY","GNMX","MRNY","LABU","RHHBY","GDOC","IBB","MEDI","NVIB","PSCH","LFSC","BK4007","BBP","BK4588","BK4585","RSPH","BMED","TECB","TBXU","IDNA","03165","HRTS","SYNB","XLVX","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BMED","BBH","XLVX","GNMX","BK4588","IE00B4R5TH58.HKD","FRTY","IE00BJJMRZ35.SGD","TBXU","LU0109394709.USD","PINK","MEDI","IDNA","SYNB","BBP","IE0009355771.USD","IE00BFTCPJ56.SGD","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IYH","IE0002141913.USD","LU0320765992.SGD","PTH","IE0009354923.USD","GDOC","BK4139","IBB","LFSC","LABU","TECB","IEIH","MRNY","RSPH","LU0889565916.HKD","BK4585","MRNX","NVIB","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LFSC","RSPH","MRNY","IE0009355771.USD","TBXU","PINK","MEDI","IE00B4R5TH58.HKD","TECB","GDOC","GNMX","LU0320765992.SGD","BBH","IE00BFTCPJ56.SGD","BK4588","IEIH","LABU","BK4585","IE0009354923.USD","MRNX","NVIB","BMED","IE00B2B36J28.USD","LU0889565916.HKD","SYNB","CANC","IE00BJJMRZ35.SGD","RVMD","XLVX","IDNA","PSCH","PTH","FRTY","IE0002141913.USD","BK4139","BBP","IBB","IYH","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748238","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748238","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748238?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:13","pubTimestamp":1787757227,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.46% to 1,977.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago  and biopharmaceutical company argenx , which advanced 2.9% and 2.6% respectively. They were followed by semiconductor company Sequans Communications  and 3D printer company Materialise , which rose 2% and 1.2% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and software firm SAP , which fell 3.5% and 2.7% respectively. They were followed by telecommunications company Ericsson  and pharmaceutical company Novo Nordisk , which lost 2.1% and 1.8% respectively.The gainers from the UK were led by biopharmaceutical companies Amarin  and Akari Therapeutics , which climbed 7.1% and 2.9% respectively. They were followed by tobacco company British American Tobacco  and biopharmaceuti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NICO","LU0162691827.USD","NVOX","BK4020","IE0002141913.USD","IE00B4R5TH58.HKD","AKTX","BK4613","IE00BKVL7J92.USD","LU2324357040.USD","BK4585","BK4023","NVOH","BK4134","AUTL","LU0889565916.HKD","MTLS","NVO","BCYC","BK4007","BK4591","IE0034235188.USD","BK4532","IBB","IE00BFTCPJ56.SGD","LU0084288595.USD","LU0109394709.USD","LU1093756168.USD","NVOC","ARGX","BK4139","DAVA","BK4141","FMED","SQNS","BK4546","IE0009355771.USD","BK4075","IE00B2B36J28.USD","BK4599","BTI","LU0006061336.USD","IE00BJJMRZ35.SGD","LU0823416689.USD","OZEM","DBVT","BK4588","ERIC","LU1093756325.SGD","BDRX","LU0648005311.SGD","LU1983260115.SGD","MREO","THNR","BK4077","LU0154236417.USD","AMRN","BK4515","IE00BJT1NW94.SGD","PRNT","TBXU","LU0320765992.SGD","BK4505","BK4554","IE00BZ1G4Q59.USD","TRVG","LU0072461881.USD","PPH","BK4528","LU2543165471.USD","SAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662239718","title":"Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662239718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662239718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:50","pubTimestamp":1787741417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Solventum Corporation (SOLV), Argenx Se (ARGX) and S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","HCSG","XLV","LU0109394709.USD","IE0034235188.USD","IE00BJT1NW94.SGD","SYRE","LU0823416689.USD","BK4198","LU1983260115.SGD","IE0009355771.USD","SOLV","IE0002141913.USD","XBI","IE00BJJMRZ35.SGD","LABU","LU2324357040.USD","LU0029874061.USD","ARGX","TBXU","BK4505","LFSC","BK4588","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4585","BK4581","FMED","BK4137","LU0320765992.SGD","LU0889565916.HKD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279030","title":"Argenx Se : Wells Fargo Raises Target Price to $1415 from $1350","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279030?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:31","pubTimestamp":1787740307,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","IE0034235188.USD","IE00BJT1NW94.SGD","LU0823416689.USD","LU1983260115.SGD","IE0009355771.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","ARGX","TBXU","BK4505","BK4588","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4585","FMED","LU0889565916.HKD","LU0320765992.SGD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4534","BK1191","BK4581","IBB","LU0289739699.SGD","BBH","LU0122379950.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU2089984988.USD","LU1571399168.USD","PJP","LU1023059063.AUD","LU0320765992.SGD","AMGN","01177","BK4599","BK1515","IE0009355771.USD","PBE","LU1983299246.USD","BIB","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","IE00BZ08YR35.GBP","LU2468319806.SGD","LU0058720904.USD","BK4139","BK4585","BK4566","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","IBBQ","BK1589","LU1057294990.SGD","SG9999001440.SGD","BK4533","BK1521","LU0868494617.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795371","title":"Argenx : UBS Raises to Buy from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795371?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:55","pubTimestamp":1787730900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nAZN4TGDPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE0009355771.USD","BK4585","LU0889565916.HKD","IE00B4R5TH58.HKD","TBXU","BK4588","LU1983260115.SGD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU2324357040.USD","ARGX","BK4505","IE0034235188.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IBB","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760351","title":"Circio and Full Circles join forces on non-viral in vivo cell therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760351?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:43","pubTimestamp":1787723005,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA and Full Circles Therapeutics have entered a research collaboration t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BK4585","FBT","CNCR","IBBQ","IBB","TBXU","LFSC","GNOM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}